<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2448-8771</journal-id>
<journal-title><![CDATA[Anestesia en México]]></journal-title>
<abbrev-journal-title><![CDATA[Anest. Méx.]]></abbrev-journal-title>
<issn>2448-8771</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Anestesiología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2448-87712018000300047</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Evaluación de la función renal posterior a la administración de fluoresceína en neurocirugía]]></article-title>
<article-title xml:lang="en"><![CDATA[Evaluation of renal function after administration of fluorescein in neurosurgery]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barraza-Zetina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Obregón-Corona]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz-García]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto Nacional de Neurología y Neurocirugía  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Instituto Nacional de Neurología y Neurocirugía Departamento Nauroanestesiologia ]]></institution>
<addr-line><![CDATA[ CDM]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto Nacional de Neurología y Neurocirugía Departamento Nauroanestesiologia ]]></institution>
<addr-line><![CDATA[ CDM]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>30</volume>
<numero>3</numero>
<fpage>47</fpage>
<lpage>54</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2448-87712018000300047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2448-87712018000300047&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2448-87712018000300047&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La cirugía guiada por fluoresceina sódica (FLS-Na), es una técnica neuroquirúrgica estándar, que incluye la administración intravenosa de este compuesto, en áreas dañadas de la barrera hematoencefálica (BHE) de las áreas tumorales y permite diferencias el tejido neoplásico del tejido cerebral sano para su resección adecuada. La principal complicación asociada a la administración de fluoresceína, es la nefropatía inducida por contraste, que se define como el aumento de 25% de los valores de creatinina sérica. En neurocirugía no se ha evaluado la insuficiencia renal posterior a la aplicación de fluoresceína intravenosa.  Objetivo:  Evaluar la función renal posterior la aplicación de FLS-Na intravenosa en los pacientes neuroquirúrgicos.  Material y métodos:  Estudio retrospectivo, observacional, transversal. Revisión de 40 expedientes de pacientes sometidos a neurocirugía, guiada por FLS-Na en el Instituto Nacional de Neurología y Neurocirugía (INNN), se estudiaron características demográficas, clínicas y de laboratorio basales, incluyendo tipo de intervención quirúrgica. Los valores basales y posquirúrgicos de creatinina sérica, uremia y tasa glomerular para evaluar la función renal. Resultados: Se incluyeron 37 expedientes, se excluyeron tres. Se clasificaron por su tasa de filtración glomerular (TGF). Se clasificaron en normales &gt; 90, 26 pacientes (70%), estadio II (60-89) 9 pacientes (24.3%), estadio III (30-59), un paciente (2.7) estadio IV (16-30) 1 paciente (2.7%), los pacientes no presentaron cambios significativos en el aumento de la creatinina sérica posterior a la aplicación intravenosa de fluoresceína en relación con su TGF respectivamente.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Surgery guided by fluorescein sodium (FLS-Na), is a technical standard neurosurgical, which includes intravenous administration of this compound, in damaged areas of the barrier (BHE) blood-brain of the tumor areas and if allows the tissue differences neoplastic healthy brain tissue to its proper resection. The main complication associated with the administration of fluorescein is nephropathy induced by contrast, which is defined as 25% of the values of serum creatinine increase. Renal failure, after the application of intravenous fluorescein, has not been evaluated in neurosurgery.  Objective:  Evaluate kidney function after the application of intravenous FLS-Na in neurosurgical patients.  Material and methods:  retrospective, observational, cross-sectional study. Review of 40 records of patients undergoing neurosurgery, guided by FLS-Na at the National Institute of Neurology and Neurosurgery (INNN), baseline, type of intervention including demographic, clinical and laboratory characteristics studied surgical. Baseline values and post-surgical of serum creatinine, uremia and rate glomerular to evaluate renal function. Results: 37 records were included, three were excluded. They were classified by the TGF. 9 patients were classified as normal &gt; 90, 26 patients (70%), stage II (60-89) (24.3%), stage III (30-59), one patient (2.7). Stadium IV (16-30) one patient (2.7%). Patients did not show significant changes in the increase of serum creatinine back to intravenous application of fluorescein in relation to its TGF respectively.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Fluoresceína]]></kwd>
<kwd lng="es"><![CDATA[función renal]]></kwd>
<kwd lng="es"><![CDATA[malformaciones arteriovenosas]]></kwd>
<kwd lng="es"><![CDATA[tumores base de cráneo]]></kwd>
<kwd lng="es"><![CDATA[gliomas]]></kwd>
<kwd lng="en"><![CDATA[Fluorescein]]></kwd>
<kwd lng="en"><![CDATA[renal function]]></kwd>
<kwd lng="en"><![CDATA[arteriovenous malformations]]></kwd>
<kwd lng="en"><![CDATA[skull base tumors]]></kwd>
<kwd lng="en"><![CDATA[gliomas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pogue]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Gibbs-Strauss]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Valdés]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Samkoe]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Review of Neurosurgical Fluorescein Imaging Methodologies]]></article-title>
<source><![CDATA[IEEE J Sel Top quantum Electron]]></source>
<year>2010</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>493-505</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandon]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lane]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aaron]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen-Gadol]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A prospective study of microscope-integrated intraoperative fluorescein video angiography during arteriovenous malformation surgery: preliminar results]]></article-title>
<source><![CDATA[Neurosurg focus]]></source>
<year>2014</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schebesch]]></surname>
<given-names><![CDATA[K-M]]></given-names>
</name>
<name>
<surname><![CDATA[Brawanski]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hohenberger]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Höhne]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fluorescein Sodium-Guided surgery of malignant Brain Tumors: History, current concepts, and Future Projects]]></article-title>
<source><![CDATA[Turk Neurosurg]]></source>
<year>2016</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>185-94</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garcia-Corrochano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Orrego]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Deza]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Heinicke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resección microquirúrgica de glioblastoma guiada con fluoresceína intraoperatoria evaluación retrospectiva]]></article-title>
<source><![CDATA[Rev Peru Med Exp salud Publica]]></source>
<year>2015</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>471-18</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Da Silva]]></surname>
<given-names><![CDATA[C.E]]></given-names>
</name>
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Duval]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of sodium fluorescein in skull base tumors]]></article-title>
<source><![CDATA[Surg Neurol Int]]></source>
<year>2010</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shaan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Matei]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Donaldson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kunai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sensitivity and specificity of intrathecal fluorescein and white light excitation for detecting intraoperative cerebrospinal fluid leak in endoscopic skull base surgery: a prospective study]]></article-title>
<source><![CDATA[J Neurosurg]]></source>
<year>2015</year>
<volume>21</volume>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kameda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Babazono]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Haruyama]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Iwamoto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kitano]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal Funtion following Fluorescein angiography in diabetic Patients With Chronic Kidney disease]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2009</year>
<volume>32</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ge]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gross Total Resection of Glioma with the Intraoperative Fluorescence guidence of Fluorescein Sodium]]></article-title>
<source><![CDATA[International J Med Sciences]]></source>
<year>2012</year>
<page-range>708-14</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Francaviglia]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Iacopino]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Constantino]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Villa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Impallaria]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fluorescein for resection of highgrade gliomas: A safety study control in a single center and review of literature]]></article-title>
<source><![CDATA[Surgical Neurology International]]></source>
<year>2017</year>
<volume>8</volume>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suzuki]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Komada]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sasaki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Matsumoto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ichikawa]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Confirmation of blood flow in perforating arteriees using cerebral angiography during aneurysm surgery]]></article-title>
<source><![CDATA[J Neurosurg]]></source>
<year>2007</year>
<volume>107</volume>
<page-range>68-73</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alemzadeh-amsari]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Beladi-Mousavi]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Feghhei]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of fluorescein on renal function among diabetic patients]]></article-title>
<source><![CDATA[Nefrologia]]></source>
<year>2011</year>
<volume>31</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>612-3</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Seungkyu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal function following fluorescein angiography]]></article-title>
<source><![CDATA[Inv Opht &amp;Vis Sci]]></source>
<year>2014</year>
<volume>55</volume>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hwan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Chul]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Soo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jun]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography]]></article-title>
<source><![CDATA[BMC Oph]]></source>
<year>2017</year>
<volume>17</volume>
<numero>46</numero>
<issue>46</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
